// App-Quantinova.ai

5530.0 : Clinical analysis of the extracellular vesicle-fingerprint score blood test to refine the prediction of clinically significant prostate cancer and avoid prostate biopsy.

Researchers

Presenter

  • Adrian S. Fairey

Principal Investigators

  • Robert J Paproski

  • Desmond Pink

  • Deborah L Sosnowski

  • Catalina Vasquez

  • Bryan Donnelly

  • M. Eric Hyndman

  • Armen G. Aprikian

  • Perrin Beatty

  • John D Lewis

Medical Centers

  • University of Alberta, Edmonton, AB, Canada

  • Nanostics Inc., Edmonton, AB, Canada

  • Department of Surgery, University of Calgary, Calgary, AB, Canada

  • University of Calgary, Calgary, AB, Canada

  • Division of Urology, Department of Surgery, McGill University, Montreal, QC, Canada

  • University of Alberta, Edmonton, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • Prostate specific antigen

  • Folate Hydrolase 1

Drug/Treatment

  • hGH

  • ghrelin

Outcome

  • N/A


Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A